ZA865826B - Peptide derivatives having a lactone or cycloamide structure,process for the preparation thereof and pharmaceutical compositions containing them - Google Patents

Peptide derivatives having a lactone or cycloamide structure,process for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
ZA865826B
ZA865826B ZA865826A ZA865826A ZA865826B ZA 865826 B ZA865826 B ZA 865826B ZA 865826 A ZA865826 A ZA 865826A ZA 865826 A ZA865826 A ZA 865826A ZA 865826 B ZA865826 B ZA 865826B
Authority
ZA
South Africa
Prior art keywords
cycloamide
lactone
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
ZA865826A
Other languages
English (en)
Inventor
Michel Vincent
Georges Remond
Jean Lepagnol
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA865826B publication Critical patent/ZA865826B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA865826A 1985-08-05 1986-08-04 Peptide derivatives having a lactone or cycloamide structure,process for the preparation thereof and pharmaceutical compositions containing them ZA865826B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8511936A FR2585709B1 (fr) 1985-08-05 1985-08-05 Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA865826B true ZA865826B (en) 1987-04-29

Family

ID=9321967

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA865826A ZA865826B (en) 1985-08-05 1986-08-04 Peptide derivatives having a lactone or cycloamide structure,process for the preparation thereof and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US4725581A (xx)
EP (1) EP0217688B1 (xx)
JP (2) JPS6233198A (xx)
AT (1) ATE56976T1 (xx)
AU (1) AU581599B2 (xx)
CA (1) CA1276397C (xx)
DE (1) DE3674525D1 (xx)
DK (1) DK364786A (xx)
ES (1) ES2000128A6 (xx)
FR (1) FR2585709B1 (xx)
GR (1) GR862059B (xx)
IE (1) IE58541B1 (xx)
NZ (1) NZ217079A (xx)
PT (1) PT83145B (xx)
ZA (1) ZA865826B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 ４−アミノピリジン誘導体及びその酸付加塩
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
FR2649110B1 (fr) * 1989-06-29 1994-10-21 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2663336B1 (fr) * 1990-06-18 1992-09-04 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IT1242002B (it) * 1990-10-03 1994-02-02 Polifarma Spa Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido quello centrale
US5504071A (en) * 1990-10-03 1996-04-02 Polifarma S.P.A. Compounds with a sequence of three radicals, the central one being α-a
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
WO1997028184A1 (en) * 1996-02-05 1997-08-07 Eli Lilly And Company Method of treating beta-amyloid peptide associated conditions using trh
DE19616509A1 (de) * 1996-04-25 1998-01-15 Asta Medica Ag Neue spezifische Immunophilin-Liganden als Antiasthmatika, Immunsuppressiva
JP2005519098A (ja) * 2002-03-01 2005-06-30 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 変形性関節症の治療方法
US7628342B2 (en) 2004-05-11 2009-12-08 Daiwa Can Company Liquefied gas dispensing nozzle and liquefied gas dispensing apparatus
EP1993527A4 (en) 2006-01-26 2009-08-05 Univ Rochester INHIBITION OF AMYLOID BETA PEPTIDE / RAGE INTERACTION AT BLOOD BRAIN BARRIER

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド
US4260601A (en) * 1979-10-23 1981-04-07 Nyegaard & Co. A/S Chemical compounds
US4293481A (en) * 1980-07-24 1981-10-06 E. R. Squibb & Sons, Inc. Tripeptide inhibitors of angiotensin-converting enzyme
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel

Also Published As

Publication number Publication date
EP0217688A1 (fr) 1987-04-08
GR862059B (en) 1986-12-24
AU6081286A (en) 1987-02-12
AU581599B2 (en) 1989-02-23
JPH0229680B2 (xx) 1990-07-02
JPH0259160B2 (xx) 1990-12-11
PT83145B (pt) 1989-03-30
DK364786D0 (da) 1986-07-31
EP0217688B1 (fr) 1990-09-26
JPH01230597A (ja) 1989-09-14
US4725581A (en) 1988-02-16
FR2585709A1 (fr) 1987-02-06
NZ217079A (en) 1988-05-30
ES2000128A6 (es) 1987-12-16
IE862085L (en) 1987-02-05
IE58541B1 (en) 1993-10-06
DK364786A (da) 1987-02-06
CA1276397C (fr) 1990-11-13
ATE56976T1 (de) 1990-10-15
DE3674525D1 (de) 1990-10-31
FR2585709B1 (fr) 1987-10-02
JPS6233198A (ja) 1987-02-13
PT83145A (fr) 1986-09-01

Similar Documents

Publication Publication Date Title
NO173726C (no) Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin
GB8718708D0 (en) Apparatus for treatment of spinal disorders
GB8716925D0 (en) Apparatus for treatment of spinal disorders
ZA87247B (en) Treatment of skin disorders
IT1147087B (it) Nuovi preparati farmaceutici per il trattamento dei disordini del sistema nervoso centrale e procedimento per la loro preparazione
GEP20084347B (en) New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them
ZA865826B (en) Peptide derivatives having a lactone or cycloamide structure,process for the preparation thereof and pharmaceutical compositions containing them
PT84899A (en) Process for the preparation of pharmaceutical compositions containing ?-phenyl-1,2-benzisoselenazol-3(2h)-one for the treatment of skin diseases
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
GB8808598D0 (en) Pharmaceutical compositions for treatment of prophylaxis of skin disorders
IL78307A0 (en) Psoralene-based bath composition for treatment of skin disorders
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
FR2575158B1 (fr) Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
PH23803A (en) New benzodiazepines,pharmaceutical composition containing them and method of use thereof
ZA881828B (en) Preparation for treatment of skin disorders
AU1875688A (en) Treatment of cerebral disorders
GB2173401B (en) Pharmaceutical compositions for the treatment of cerebrovascular and aging brain disorders
Elsendoorn Acceptability of temporal variations in synthetic speech: A preliminary investigation.
ES2007415A6 (es) Procewdimiento de obtencioon de citidina-difosfo-dimetiletanolamina.
HU895238D0 (en) Process for the preparation of pharmaceutical composition suitable for the treatment of pyogenous skin diseases
HU895239D0 (en) Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases
AU8066187A (en) Method and therapeutic compositions for the treatment of bleeding disorders
IL93030A0 (en) Composition containing thymo-pentin for topical treatment of skin disorders
GB8817446D0 (en) Treatment of various blood disorders